Year To Quarter End Statement Of Income

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7301461

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Year to quarter end statement of income
Statement of income
Net sales
28,550,181,000 JPY
375,859,000 JPY
13,802,313,000 JPY
42,352,494,000 JPY
42,422,617,000 JPY
42,728,354,000 JPY
-305,736,000 JPY
23,903,955,000 JPY
12,700,344,000 JPY
37,001,503,000 JPY
36,678,404,000 JPY
-323,099,000 JPY
397,202,000 JPY
36,604,300,000 JPY
Cost of sales
11,409,066,000 JPY
9,631,957,000 JPY
Gross profit (loss)
31,013,551,000 JPY
27,046,446,000 JPY
Selling, general and administrative expenses
24,554,334,000 JPY
21,719,007,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
5,830,595,000 JPY
118,312,000 JPY
3,121,985,000 JPY
8,952,580,000 JPY
6,459,216,000 JPY
9,070,892,000 JPY
-2,611,676,000 JPY
5,257,968,000 JPY
2,526,140,000 JPY
7,908,202,000 JPY
5,327,439,000 JPY
-2,580,762,000 JPY
124,092,000 JPY
7,784,109,000 JPY
Non-operating income
Interest income
120,528,000 JPY
46,176,000 JPY
Dividend income
225,858,000 JPY
192,672,000 JPY
Non-operating income
1,791,596,000 JPY
407,090,000 JPY
Non-operating expenses
Interest expenses
232,249,000 JPY
226,110,000 JPY
Non-operating expenses
301,438,000 JPY
238,591,000 JPY
Ordinary profit (loss)
7,949,373,000 JPY
5,495,938,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,903,000 JPY
JPY
Extraordinary income
2,903,000 JPY
923,332,000 JPY
Extraordinary losses
Extraordinary losses
200,407,000 JPY
6,336,000 JPY
Profit (loss) before income taxes
7,751,869,000 JPY
6,412,933,000 JPY
Income taxes
1,625,522,000 JPY
1,005,062,000 JPY
Profit (loss)
6,126,346,000 JPY
5,407,870,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.